Cidara Therapeutics (CDTX) Free Cash Flow (2018 - 2025)
Cidara Therapeutics (CDTX) free cash flow from Sep 30, 2018 to Sep 30, 2025. The TTM Cidara Therapeutics (CDTX) free cash flow is -$133M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Cidara Therapeutics (CDTX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -16.99% |
| 3 Years TTM | +80.78% |
| 5 Years TTM | +25.05% |
| All Time TTM | +46.63% |
Annual Free Cash Flow change of Cidara Therapeutics (CDTX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$104M | -41.40% |
| 2024 | -$177M | +670.10% |
| 2023 | -$23M | -19.76% |
| 2022 | -$29M | +13.14% |
| 2021 | -$25M | -53.72% |
| 2020 | -$55M | +91.11% |
| 2019 | -$29M | -49.77% |
| 2018 | -$57M | N/A |
Comparison Cidara Therapeutics (CDTX) five years free cash flow CAGR with competitors
Cidara Therapeutics (CDTX) five years free cash flow CAGR is 18.52%.